Wenn auch alles anders aussieht, hat sich doch nicht alles verändert...
Biblio
] . Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A [Internet]. 1998;95(2):548 - 53. http://view.ncbi.nlm.nih.gov/pubmed/9435229
Marc Achen et al., PNAS 1998 (447.59 KB)
Marc Achen et al., PNAS 1998 (447.59 KB). Suppressive effects of vascular endothelial growth factor-B on tumor growth in a mouse model of pancreatic neuroendocrine tumorigenesis. PLoS ONE [Internet]. 2010;5(11):e14109. http://view.ncbi.nlm.nih.gov/pubmed/21124841 Imke Albrecht et al., PLoS One 2010 (3.37 MB)
Imke Albrecht et al., PLoS One 2010 (3.37 MB). Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res [Internet]. 2009;104(11):1302 - 12. http://view.ncbi.nlm.nih.gov/pubmed/19443835 Andrey Anisimov et al., Circulation Research 2009 (8.03 MB) Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB)
Andrey Anisimov et al., Circulation Research 2009 (8.03 MB) Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB). Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest [Internet]. 2005;115(2):247 - 57. http://view.ncbi.nlm.nih.gov/pubmed/15668734 Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB)
Peter Baluk et al., Journal of Clinical Investigation 2005 (1.89 MB). Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation [Internet]. 2010;122(17):1725 - 33. http://view.ncbi.nlm.nih.gov/pubmed/20937974 Maija Bry et al., Circulation 2010 (2.23 MB) Maija Bry et al., Circulation 2010, supplement (17.77 MB)
Maija Bry et al., Circulation 2010 (2.23 MB) Maija Bry et al., Circulation 2010, supplement (17.77 MB). Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem [Internet]. 1997;272(40):25176 - 83. http://view.ncbi.nlm.nih.gov/pubmed/9312130 Dmitry Chilov et al., The Journal of Biological Chemistry 1997 (517.68 KB)
Dmitry Chilov et al., The Journal of Biological Chemistry 1997 (517.68 KB). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res [Internet]. 2001;88(6):623 - 9. http://view.ncbi.nlm.nih.gov/pubmed/11282897 Bernd Enholm et al., Circulation Research 2001 (2.93 MB)
Bernd Enholm et al., Circulation Research 2001 (2.93 MB). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol [Internet]. 2003;161(6):1163 - 77. http://view.ncbi.nlm.nih.gov/pubmed/12810700 Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB)
Holger Gerhardt et al., The Journal of Biological Chemistry 2003 (2.24 MB). Lymphatics and the eye. [Finnish]. Duodecim Lääketieteellinen Aikakauskirja [Internet]. 2020;136(16):1777-1788. https://www.duodecimlehti.fi/lehti/2020/16/duo15739 Gucciardo et al. Lymphatics and the Eye (English version). (3.31 MB)
Gucciardo et al. Lymphatics and the Eye (English version). (3.31 MB). Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res [Internet]. 2005;65(11):4739 - 46. http://view.ncbi.nlm.nih.gov/pubmed/15930292 Yulong He et al., Cancer Research 2005 (1.82 MB)
Yulong He et al., Cancer Research 2005 (1.82 MB). The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis. Cancer Res [Internet]. 2008;68(12):4754 - 62. http://view.ncbi.nlm.nih.gov/pubmed/18559522 Caroline Heckman et al., Cancer Research 2008 (504.8 KB)
Caroline Heckman et al., Cancer Research 2008 (504.8 KB). Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation [Internet]. 2000;102(18):2262 - 8. http://view.ncbi.nlm.nih.gov/pubmed/11056103 Mikko Hiltunen et al., Circulation 2000 (1.44 MB)
Mikko Hiltunen et al., Circulation 2000 (1.44 MB). Genesis and pathogenesis of lymphatic vessels. Cell Tissue Res [Internet]. 2003;314(1):69 - 84. http://view.ncbi.nlm.nih.gov/pubmed/12942362 Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB)
Michael Jeltsch et al., Cell and Tissue Research 2003 (562.33 KB). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science (80- ) [Internet]. 1997;276(5317):1423 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9162011 Michael Jeltsch et al., Science 1997 (293.65 KB)
Michael Jeltsch et al., Science 1997 (293.65 KB). VEGFR-3 Ligands and Lymphangiogenesis [Internet]. University of Helsinki. 2002. http://ethesis.helsinki.fi/julkaisut/mat/bioti/vk/jeltsch Michael Jeltsch, PhD Thesis, 2002 (1.75 MB)
Michael Jeltsch, PhD Thesis, 2002 (1.75 MB). Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J Biol Chem [Internet]. 2006;281(17):12187 - 95. http://view.ncbi.nlm.nih.gov/pubmed/16505489 Michael Jeltsch et al., The Journal of Biological Chemistry 2006 (1.04 MB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 1 (1.01 MB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 2 (596.06 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 3 (738.98 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 4 (710.03 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 5 (163.64 KB)
Michael Jeltsch et al., The Journal of Biological Chemistry 2006 (1.04 MB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 1 (1.01 MB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 2 (596.06 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 3 (738.98 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 4 (710.03 KB) Michael Jeltsch et al., The Journal of Biological Chemistry 2006, supplemental data 5 (163.64 KB). Drug-induced lymphangiogenesis. In 3. Schweizer Lymphsymposium [Internet]. Juzo; 2021. https://doi.org/10.5281/zenodo.6034307 Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)
Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB). What you should know about VEGF-C when working with lymphatics [German]. In Lymphologie 2017 [Internet]. Bad Soden (Frankfurt), Germany; 2017. https://jeltsch.org/Abstrakt-BadSoden2017 Extended Abstract (published in Vasomed, 2018) (226.5 KB)
Extended Abstract (published in Vasomed, 2018) (226.5 KB). Lymphatic-to-blood vessel transdifferentiation in zebrafish. Nature Cardiovascular Research [Internet]. 2022;1(6):539 - 541. https://rdcu.be/cOjJ0
. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D. eLife [Internet]. 2019;8:e44478. https://elifesciences.org/articles/44478 Jha & Rauniyar et al. 2019 (3.84 MB)
Jha & Rauniyar et al. 2019 (3.84 MB). Mechanism of VEGF-C Activation and Effect on Lymphatic Vessel Growth and Regeneration [Internet]. [Helsinki, Finland]: University of Helsinki; 2020. https://helda.helsinki.fi/handle/10138/314714 Jha - 2020 - Mechanism of VEGF-C Activation and Effect on Lymphatic Vessel Growth and Regeneration (1.96 MB)
Jha - 2020 - Mechanism of VEGF-C Activation and Effect on Lymphatic Vessel Growth and Regeneration (1.96 MB). Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol [Internet]. 1997;173(2):211 - 5. http://view.ncbi.nlm.nih.gov/pubmed/9365524 Vladimir Joukov et al., Journal of Cellular Physiology 1997 (127.57 KB)
Vladimir Joukov et al., Journal of Cellular Physiology 1997 (127.57 KB). Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J [Internet]. 1997;16(13):3898 - 911. http://view.ncbi.nlm.nih.gov/pubmed/9233800 Vladimir Joukov et al., EMBO Journal 1997 (729.21 KB)
Vladimir Joukov et al., EMBO Journal 1997 (729.21 KB). Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. Jussila et al., 2001 (279.47 KB)
Jussila et al., 2001 (279.47 KB). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol [Internet]. 2004;5(1):74 - 80. http://view.ncbi.nlm.nih.gov/pubmed/14634646 Marika Kärkkäinen et al., Nature Immunology 2004 (3.01 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 1 (1.27 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 2 (1.23 MB)
Marika Kärkkäinen et al., Nature Immunology 2004 (3.01 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 1 (1.27 MB) Marika Kärkkäinen et al., Nature Immunology 2004, supplementary data 2 (1.23 MB)